Financial Advocates Investment Management Has $2.23 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Financial Advocates Investment Management lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.3% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,381 shares of the healthcare conglomerate’s stock after selling 246 shares during the quarter. Financial Advocates Investment Management’s holdings in UnitedHealth Group were worth $2,231,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. Signature Resources Capital Management LLC boosted its stake in shares of UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 18 shares during the period. Saxony Capital Management LLC grew its stake in UnitedHealth Group by 3.5% during the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after buying an additional 18 shares in the last quarter. Continuum Advisory LLC lifted its stake in UnitedHealth Group by 0.6% during the second quarter. Continuum Advisory LLC now owns 3,410 shares of the healthcare conglomerate’s stock worth $1,737,000 after purchasing an additional 19 shares during the last quarter. Veracity Capital LLC grew its position in UnitedHealth Group by 1.5% during the 1st quarter. Veracity Capital LLC now owns 1,335 shares of the healthcare conglomerate’s stock worth $660,000 after acquiring an additional 20 shares during the last quarter. Finally, Rodgers Brothers Inc. boosted its position in UnitedHealth Group by 2.4% during the 1st quarter. Rodgers Brothers Inc. now owns 842 shares of the healthcare conglomerate’s stock worth $417,000 after buying an additional 20 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded down $0.66 during midday trading on Thursday, reaching $587.88. The stock had a trading volume of 441,792 shares, compared to its average volume of 4,099,191. The firm’s 50-day moving average price is $541.92 and its 200 day moving average price is $510.85. The firm has a market capitalization of $542.86 billion, a PE ratio of 35.96, a P/E/G ratio of 1.63 and a beta of 0.59. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $592.84. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The firm had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period last year, the company earned $6.14 earnings per share. As a group, research analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.43%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Insider Buying and Selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. TD Cowen increased their price target on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Royal Bank of Canada boosted their price target on UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Wednesday, August 21st. Barclays raised their target price on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Finally, Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. One investment analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.